1 February 2024 false No description of principal activity Taxfiler 2024.6 11283715 business:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 11283715 2024-01-31 11283715 2024-02-01 2025-01-31 11283715 business:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 11283715 business:FilletedAccounts 2024-02-01 2025-01-31 11283715 2025-01-31 11283715 2024-01-31 11283715 core:WithinOneYear 2025-01-31 11283715 core:WithinOneYear 2024-01-31 11283715 core:ShareCapital core:PreviouslyStatedAmount 2025-01-31 11283715 core:ShareCapital core:PreviouslyStatedAmount 2024-01-31 11283715 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-01-31 11283715 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-01-31 11283715 core:PreviouslyStatedAmount 2025-01-31 11283715 core:PreviouslyStatedAmount 2024-01-31 11283715 business:SmallEntities 2024-02-01 2025-01-31 11283715 business:Director1 2024-02-01 2025-01-31 11283715 countries:EnglandWales 2024-02-01 2025-01-31 11283715 business:RegisteredOffice 2024-02-01 2025-01-31 11283715 business:OrdinaryShareClass1 2024-02-01 2025-01-31 11283715 business:OrdinaryShareClass1 2023-02-01 2024-01-31 11283715 2023-02-01 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 11283715 (England and Wales)
Cambridge Functional Medicine Ltd Unaudited accounts for the year ended 31 January 2025
Cambridge Functional Medicine Ltd Statement of financial position as at 31 January 2025
2025
2024
Notes
£
£
Current assets
Cash at bank and in hand
4,598
19,230
Creditors: amounts falling due within one year
4
(885,885)
(744,436)
Net current liabilities
(881,287)
(725,206)
Net liabilities
(881,287)
(725,206)
Capital and reserves
Called up share capital
5
100
100
Profit and loss account
(881,387)
(725,306)
Shareholders' funds
(881,287)
(725,206)
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 October 2025 and were signed on its behalf by
Alex Wilber Director Company Registration No. 11283715
- 2 -
Cambridge Functional Medicine Ltd Notes to the Accounts for the year ended 31 January 2025
1
Statutory information
Cambridge Functional Medicine Ltd is a private company, limited by shares, registered in England and Wales, registration number 11283715. The registered office is 28 High Street, Bidford-on-Avon, Alcester, B50 4AA.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
4
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
822,539
682,539
Trade creditors
-
1,156
Taxes and social security
316
3,947
Other creditors
713
5,876
Loans from directors
61,332
49,980
Accruals
985
938
885,885
744,436
5
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
6
Average number of employees
During the year the average number of employees was 3 (2024: 3).
- 3 -